MBX Biosciences, Inc. Common Stock
Rachunek Zysków i Strat
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
| Rok finansowy |
2023 |
2023 |
2023 |
2024 |
2024 |
2024 |
2024 |
2025 |
| Kwartał |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
| Data |
2023-06-30 |
2023-09-30 |
2023-12-31 |
2024-03-31 |
2024-06-30 |
2024-09-30 |
2024-12-31 |
2025-03-31 |
| Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Przychód Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| Marża brutto |
-inf% |
0.0% |
0.0% |
-inf% |
-inf% |
0.0% |
0.0% |
0.0% |
| Koszty i Wydatki (mln) |
-8 |
11 |
10 |
-13 |
-17 |
20 |
19 |
0 |
| EBIT (mln) |
-8 |
-11 |
-10 |
-13 |
-17 |
-20 |
-19 |
-27 |
| EBIT Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
108.0% |
79.2% |
86.3% |
99.3% |
| EBIT (%) |
None |
None |
None |
None |
None |
None |
None |
None |
| Przychody fiansowe (mln) |
0 |
1 |
1 |
1 |
1 |
1 |
3 |
0 |
| Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Amortyzacja (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EBITDA (mln) |
-8 |
-11 |
-7 |
-12 |
-16 |
-20 |
-19 |
-27 |
| EBITDA(%) |
None |
None |
None |
None |
None |
None |
None |
None |
| NOPLAT (mln) |
-8 |
-10 |
-9 |
-12 |
-16 |
-18 |
-16 |
-24 |
| Podatek (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Zysk Netto (mln) |
-8 |
-10 |
-9 |
-12 |
-16 |
-18 |
-16 |
-24 |
| Zysk netto Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
108.4% |
78.5% |
76.3% |
93.6% |
| Zysk netto (%) |
None |
None |
None |
None |
None |
None |
None |
None |
| EPS |
-0.23 |
-0.32 |
0.0 |
-0.37 |
-0.48 |
-2.78 |
-0.47 |
-0.71 |
| EPS (rozwodnione) |
-0.23 |
-0.32 |
0.0 |
-0.37 |
-0.48 |
-2.78 |
-0.47 |
-0.71 |
| Ilośc akcji (mln) |
33 |
32 |
0 |
33 |
33 |
7 |
33 |
33 |
| Ważona ilośc akcji (mln) |
33 |
32 |
0 |
33 |
33 |
7 |
33 |
33 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |